Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2015.0154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Systemic Chemotherapy in Gastric Cancer: Where Do We Stand Today?

Oncologist
Cancer ResearchMedicineOncology
1998English

Targeting Angiogenesis in Cancer Treatments: Where Do We Stand?

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2016English

High Energy Neutrino Astronomy: Where Do We Stand, Where Do We Go?

Physics of Particles and Nuclei
High Energy PhysicsNuclear
2018English

Schistosomiasis Vaccines: Where Do We Stand?

Parasites and Vectors
ParasitologyInfectious Diseases
2016English

Where Do We Stand After Coty?

Competition Law Journal
2018English

Blockchain in Academia: Where Do We Stand and Where Do We Go?

2020English

C-Reactive Protein in Bladder Cancer: Where Do We Stand?

Nature Reviews Urology
Urology
2013English

Quantum Computers: Where Do We Stand?

Europhysics News
AstronomyPhysics
2005English

Plural Forms of Organization: Where Do We Stand?

Managerial and Decision Economics
ManagementBusinessInternational ManagementStrategyManagement ScienceInnovationManagement of TechnologyOperations Research
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy